title: [beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League].
authors.affiliation: Robert Koch-Klinik, Thoraxzentrum des Klinikums St. Georg, Leipzig. adrian.gillissen@sanktgeorg.de
authors.forename: A
authors.initials: A
authors.lastname: Gillissen
authors.forename: D
authors.initials: D
authors.lastname: Berdel
authors.forename: R
authors.initials: R
authors.lastname: Buhl
authors.forename: C-P
authors.initials: CP
authors.lastname: Crieé
authors.forename: P
authors.initials: P
authors.lastname: Kardos
authors.forename: H
authors.initials: H
authors.lastname: Magnussen
authors.forename: K F
authors.initials: KF
authors.lastname: Rabe
authors.forename: M
authors.initials: M
authors.lastname: Rolke
authors.forename: C
authors.initials: C
authors.lastname: Vogelmeier
authors.forename: H
authors.initials: H
authors.lastname: Worth
authors.forename: J C
authors.initials: JC
authors.lastname: Virchow
mesh_terms: D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D001741:Black or African American; D001249:Asthma / Q000188:drug therapy* / Q000208:ethnology / Q000401:mortality; D001993:Bronchodilator Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013566:Sympathomimetics / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology; D044465:White People
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D013566:Sympathomimetics